Fipexide

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Fipexide
Fipexide.svg
Systematic (IUPAC) name
1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-
2-(4-chlorophenoxy)ethanone
Clinical data
Legal status ?
Identifiers
CAS number 34161-24-5
ATC code N06BX05
PubChem CID 3351
ChemSpider 3234 YesY
UNII TG44VME01D YesY
KEGG D07345 YesY
ChEMBL CHEMBL254857 YesY
Chemical data
Formula C20H21ClN2O4 
Mol. mass 388.845 g/mol
 YesY (what is this?)  (verify)

Fipexide (Attentil, Vigilor) is a psychoactive drug of the piperazine chemical class which was developed in Italy in 1983.[1] It was used as a nootropic drug in Italy and France, mainly for the treatment of senile dementia,[2] but is no longer in common use due to the occurrence of rare adverse drug reactions including fever[3] and hepatitis. Fipexide is similar in action to other nootropic drugs such as piracetam and is structurally similar to another more well-known nootropic, centrophenoxine. Chemically, it is an amide union of parachlorophenoxyacetate and methylenedioxybenzylpiperazine (BZP), and has been shown to metabolize to the latter, which plays a significant role in its effects.

See also[edit]

References[edit]

  1. ^ Missale C, Pasinetti G, Govoni S, Spano PF, Trabucchi M. Fipexide: a new drug for the regulation of dopaminergic system at the macromolecular level. Bollettino Chimico Farmaceutico. 1983 Feb;122(2):79-85.
  2. ^ Bompani R, Scali G. Fipexide, an effective cognition activator in the elderly: a placebo-controlled, double-blind clinical trial. Current Medical Research and Opinion. 1986;10(2):99-106.
  3. ^ Guy C, Blay N, Rousset H, Fardeau V, Ollagnier M. Fever caused by fipexide. Evaluation of the national pharmacovigilance survey. Therapie. 1990 Sep-Oct;45(5):429-31.